Using Continuous Glucose Monitors After Gestational Diabetes
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Recruiting
Observational Study
Gestational Diabetes
Hyperglycemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Ohio State University · Other
Who this trial is looking for
This trial is looking for women who recently had gestational diabetes after their pregnancy. Participants will wear a small glucose monitor for a few weeks and answer questions about their experience with it.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a viable singleton pregnancy
- I can understand the study and give written consent in English
- I had gestational diabetes in my recent pregnancy
You may not be able to join if
- I have pregestational diabetes
- I am taking diabetes medications right after delivery
- I delivered my baby preterm (before 37 weeks)
- I am having twins or more
- I do not have access to a smartphone
- I cannot or do not want to wear the glucose monitor
- I participated in this trial in a previous pregnancy
- I have a skin allergy to adhesives or glucose monitors
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women with a viable singleton intrauterine pregnancy
* Able to understand the study, and having understood, provide written informed consent in English
* Recent pregnancy affected by gestational diabetes
Exclusion Criteria:
* Pregestational Diabetes (Type I or Type II)
* Con…
Contacts